MARKET

MSLE

MSLE

Satellos Bioscience Inc
NASDAQ
6.10
+0.48
+8.54%
Opening 10:49 06/25 EDT
OPEN
5.71
PREV CLOSE
5.62
HIGH
6.11
LOW
5.71
VOLUME
16.31K
TURNOVER
--
52 WEEK HIGH
13.39
52 WEEK LOW
4.680
MARKET CAP
127.07M
P/E (TTM)
-3.3655
1D
5D
1M
3M
1Y
5Y
1D
Satellos to present SAT-3247 clinical program update at ICNMD 2026
PUBT · 3h ago
Satellos to present 6-month follow-up data from SAT-3247 Phase 2 TRAILHEAD trial at ICNMD 2026
PUBT · 3h ago
Weekly Report: what happened at MSLE last week (0615-0619)?
Weekly Report · 3d ago
Satellos Bioscience Shareholders Back Board Slate and Auditor at June 17 Annual Meeting
TipRanks · 06/18 10:33
Satellos Bioscience Shareholders Back Board Slate and Auditor at June 17 AGM
TipRanks · 06/17 23:14
Satellos Bioscience Announces Results of Annual Meeting of Shareholders
Barchart · 06/17 16:00
Weekly Report: what happened at MSLE last week (0608-0612)?
Weekly Report · 06/15 09:15
Weekly Report: what happened at MSLE last week (0601-0605)?
Weekly Report · 06/08 09:14
More
About MSLE
Satellos Bioscience Inc. is a Canada-based clinical-stage drug development company. The Company is focused on restoring natural muscle repair and regeneration in degenerative muscle diseases. Through its research, the Company has developed SAT-3247, a first-of-its-kind, orally administered small molecule drug designed to address deficits in muscle repair and regeneration. SAT-3247 targets AAK1, a key protein that has identified as capable of replacing the signal normally provided by dystrophin in muscle stem cells to effect repair and regeneration. It is also leveraging its proprietary discovery platform MyoReGenX to identify additional muscle diseases or injury conditions where restoring muscle repair and regeneration may have therapeutic benefit and represent future clinical development opportunities. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process.

Webull offers Satellos Bioscience Inc stock information, including NASDAQ: MSLE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MSLE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MSLE stock methods without spending real money on the virtual paper trading platform.